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Abstract 
Objective: The aim of this study was to explore whether attentional demands are involved in gait improvements in 
Parkinson disease (PD) patients when they walk on a treadmill. 
Design: Nineteen individuals with idiopathic PD and 19 age-matched healthy controls participated in this study. 
Participants walked on a treadmill and on overground under single task (walk only) and dual task (walk performing a 
simultaneous cognitive task) conditions. The dual-task paradigm was used to reveal the attention allocation behavior. 
Gait pattern and cognitive performance was measured. 
Results: The PD group showed reduced gait variability when walking on a treadmill in comparison with overground. 
However, this reduction did not deteriorate during the dual task. Moreover, there were no differences in the cognitive 
performance between treadmill and overground walking. 
Conclusions: This study does not support the proposition attentional resource allocation as a possible mechanism for 
the treadmill-associated gait improvements observed in PD. 
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Gait disorders are among the most significant impairments in Parkinson disease (PD) that severely 
affect the individual’s quality of life.1 PD gait is characterized by a reduced gait speed, increased stride-
to-stride variability, and a specific difficulty to regulate stride length.
1
 In addition, people with PD suffer 
a deficit in executive functions and attention abilities (see Dirbenger and Jahanshahi 
2
 for an extensive 
review of executive deficits in PD and Yogev-Seligmann et al.
3
 for a review of the role of executive 
function and attention in gait). These cognitive dysfunctions could explain the exacerbated gait 
impairments in PD subjects (ie, reduced walking speed and stride length, and increased stride-to-stride 
variability) when they perform a concurrent task.
4–6
 Previous studies have examined the relationship 
between cognition and gait performance in people with PD using a secondary task during walking (dual-
task paradigm).
4,7–10
 Dual tasking (DT) is a component of executive function, which refers to the ability to 
allocate attention to tasks that are performed at the same time.
11
 Although several theories have been 
proposed to explain DT interference, all of them agree that when two tasks are performed concurrently, 
performance decrements are observed in one or both tasks.
10,11
 For instance, and according to the capacity 
sharing model,
5,12
 when two attentionally demanding tasks are performed simultaneously, competition of 
attentional resources results in the deterioration of performance in one or both of the tasks. Therefore, it is 
important to explore the role of attention associated with therapeutic strategies to improve the gait in 
subjects with PD. 
In the last decade, several studies have shown the therapeutic use of treadmill training for gait 
rehabilitation in PD.
13
 Several weeks of treadmill training lead to an improvements in several gait 
parameters such as enlarged stride length, increased speed, decreased double support, reduced swing time 
variability, and reduced stride length variability between others.
12,14–16
 Notably, subjects with PD 
increased their stride length after 5 weeks of treadmill training but not when the training consisted of 
walking overground.
14
 A recent study showed improvements in walking speed and walking endurance 
even 6 months after the treadmill training.
15
 In addition to these long-term effects of treadmill training, 
immediate improvements on overground gait, such as faster speed and longer step length, have been 
reported after a single treadmill session in PD.
17
 
  
The therapeutic effect of treadmill could be explained as a specific gait modulation in PD subjects 
when walking over this device. PD subjects walk on a treadmill with lower stride-to-stride variability 
18
 
and higher length step in comparison with walking overground.
17
 However, the mechanisms underlying 
these positive treadmill effects in PD remain unknown even though several theories have been 
postulated.
19,20
 One of these theories refers to attentional resources. Although regulation of gait pattern is 
an automatic process that does not require attention in healthy adults,
4
 people with PD are able to improve 
their gait when they direct their attention to their walking movement,
21,22
 suggesting an impairment in the 
automatic control of the gait. Thus, it is plausible that the stable environment and absence of distracters 
associated with walking over the treadmill allow PD patients to allocate attention to their gait in 
comparison with an overground walking condition. However, to the best of our knowledge, there are no 
studies that have explored the role of attention during treadmill walking in subjects with PD. 
Therefore, the main goal of this study was to investigate whether attention could be an underlying 
mechanism for the gait improvements observed during treadmill walking in PD. To this end, and using a 
dual-task paradigm, the present work compared the gait pattern in PD and controls when walking over the 
treadmill and when walking overground during the performance of a concurrent cognitive task. The 
proposed hypothesis was that if the gait improvements observed while walking over a treadmill depend 
on attentional resources, performance of a cognitive task will lead to impairment in one or both of the 
tasks. 
Methods 
Subjects 
Nineteen individuals diagnosed with idiopathic PD by a neurologist, according to the United Kingdom 
Bank Criteria 
23
 (11 males and 8 females, mean age = 59.79 ± 12.63), and 19 age-matched healthy 
controls (11 males and 8 females, mean age = 59.53 ± 12.1) were recruited for the study from a local 
community. Inclusion criteria for participants with PD was diagnosis of idiopathic PD, the ability to walk 
for 10 minutes without stopping or walking assistance, absence of neurologic disorders other than PD, 
and absence of orthopedic, cardiovascular, or visual disturbances that could affect gait. Healthy controls 
were included if they did not have a history of neurological pathology or other disease that could affect 
the ability to walk. All participants did not use a treadmill for at least 12 months before the experiment. 
No participant showed dementia as assessed by a mini-mental state examination (MMSE). The level of 
severity of motor signs associated with PD was measured in ON state (45 min–1.5 h after medication 
intake) using the Unified Parkinson’s Disease Rating ScalePart-III 24 (UPDRS-III) and Hoehn and Yahr 
scale 
25
 (H&Y). A neurologist confirmed the ON state. All participants gave their written informed 
consent according to the declaration of Helsinki (1964) before entering the study. The experimental 
procedures were approved by the local ethics committee. 
Apparatus 
A treadmill with handrails (SportsArt 6300; Sports Arts Fitness) was used. Gait performance 
overground and on the treadmill was recorded using an optical detection system (OptoGait; Microgait, 
USA). This optical and modular system included transmitting and receiving bars of infrared LEDs. The 
apparatus detected the interruptions of the communication between the bars during walking. Wireless 
headphones (Philips Hi.Fi, SHD8600UG) were used for the cognitive task. 
Testing Procedure 
All participants were tested in four conditions: overground single task (ST: walk only), overground 
dual task (DT: walk and perform a cognitive task), treadmill ST, and treadmill DT. Single and dual task 
conditions were arranged in a random order. However, overground and treadmill conditions were not 
counterbalanced because it has been reported that treadmill walking has significant and long-lasting 
effects on the speed and frequency of consequent overground walking.
17
 The experimental sessions were 
carried out while patients were ON medication, confirmed by a neurologist evaluating the motor items of 
the UPRDS scale (Fig. 1). 
  
 
 
 
Figure 1. Flowchart of study recruitment and completion 
The cognitive task consisted of a phoneme monitoring paradigm.
26
 The phoneme monitoring task has 
been previously used in several studies of PD and gait.
14,27,28
 Participants were asked to listen to a 1-
minute-long narration through wireless headphones and they had to count the number of times that two 
pre-specified words were repeated in the narration. At the end of the task, participants reported the 
number of times the words were repeated in the text. They were not allowed to use their voice or fingers 
to help in the count. The subjects were not given any instructions or information regarding prioritization 
of the tasks. Baseline measurement of the cognitive task (without walking) was performed in a sitting 
position at the beginning of the session. A total of 14 texts were used, which were arranged in a 
randomized order for the different cognitive tests (baseline measurement, overground DT, and treadmill 
DT). The two pre-specified words differed for each text. For the dual task condition, the subjects were not 
given any instructions or information regarding prioritization of the tasks. 
The overground walking tests started with a practical trial of 3 minutes to familiarize the subjects with 
the walkway and with their self-selected comfortable speed. Participants were tested at their self-selected 
comfortable speed, up and down an 8-m walkway, for a total time of 1 min. The gait parameters were 
recorded during the straight walk but not during the turns. Thus, each overground condition (ST or DT) 
was repeated twice to obtain the same number of steps to that in the treadmill conditions. The only 
instruction that participants received was to walk at their preferred speed. 
The treadmill walking tests started with a period of familiarization of 3 minutes to reach, on the 
treadmill, the gait speed previously established during the overground condition (ST). During the 
familiarization period, all participants were instructed to keep their steps close to the front of the treadmill 
to keep their body erected. The treadmill tests consisted of two new blocks of 3 minutes for ST and DT 
conditions. During the first minute, belt speed was increased to reach the overground speed. The 
measurements were taken in the second minute of each block (ST and DT). All participants walked on the 
treadmill holding the handrails 
14,20
 because some subjects, specifically individuals with PD, did not feel 
safe to walk without the handrail support. Participants walked on the treadmill under the close supervision 
of a physical therapist. To minimize fatigue effects, rest periods of 3 minutes between treadmill blocks 
and overground measures were included. 
  
Data Analysis 
The following variables of gait were evaluated: overground speed (m/s), stride length (m), stride 
frequency (Hz), coefficient of variation (CV) of stride length (%), and CV of stride frequency (%). 
Coefficients of variation were calculated using the following formulas: (standard deviation/stride length) 
× 100; (standard deviation/stride frequency) × 100. The outcomes of gait measurements were recorded 
during the tests with OptoGait v.1.9.9.0 software (Microgait, USA) and were exported to Excel format for 
offline analysis. 
The variable of the cognitive task was called “cognitive performance”. The cognitive performance 
was evaluated by calculating the percentage of mistakes made when counting the two pre-specified 
words. 
Statistical Analysis 
To determine group and gait differences, a t test was performed using the demographic and 
anthropometric measures. A repeated-measures analysis of variance (ANOVA) was carried out to 
compare the changes in gait in different conditions. Two-way ANOVA was used for gait speed (analyzed 
only overground), with “task” as the within-subject factor and “group” as the between-subject factor. For 
the remaining variables of gait, three-way ANOVA was used with “surface” (overground and treadmill) 
and “task” (single task and dual task) as within-subject factors and “group” (PD and control) as between-
subject factor. Post hoc t tests were computed. Wilcoxon rank test was applied for each group to compare 
cognitive performance between baseline, overground, and treadmill conditions. Mann–Whitney test was 
used to compare cognitive performance between PD patients and controls for baseline, overground, and 
treadmill conditions. All statistical analysis was performed using PASW Statistics 18. With the exception 
of percentage of mistakes, none of the data violated the normality assumption according to Shapiro-Wilk 
test. A P value <=0.05 was considered statistically significant. 
Results 
T tests showed no significant differences for age, leg length, weight, and height between PD and 
control groups (Table 1). Means, standard deviations, and ANOVA results of gait variables are shown in 
Tables 2 and 3, respectively. 
Table 1. Characteristics of PD and control groups 
 PD Control Group Differences 
    
Age (yr)  59.68 ± 12.81 59.53 ± 12.10 NS 
Weigh± (kg)  79.91 ± 14.66 73.63 ± 8.6 NS 
Leg lengtha (m)  87.37 ± 7.22 85.64 ± 6.97 NS 
Height (m)  1.65 ± 0.072 1.65 ± 0.08 NS 
MMSE  29.38 ± 1.02 29.52 ± 0.89 NS 
Disease duration (yr)  5.08 ± 3.83   
UPDRS-III  21.06 ± 10.69   
H&Y stage 1 (n = 4); 1.5 (n = 3); 2 (n = 6); 2.5 (n = 6)   
(subjects in each stage)   
   
 
Values are mean ± SD. t test analysis for group differences. 
a Distance from the great trochanter to the floor. 
PD indicates Parkinson disease; MMSE, Mini-Mental State Examination; H&Y, Hoen and Yahr; UPDRS-III, Unified Parkinson’s 
Disease Rating Scale motor section; NS, not significant; n, sample 
  
Table 2. Mean ± standard deviations of gait variables in PD and control groups 
 PD  Control 
 Overground  Treadmill  Overground  Treadmill 
 ST DT  ST DT  ST DT  ST DT 
            
Gait speed 
(m/s) 
1.07 ± 0.23 1.01 ± 0.24  1.07 ± 0.23 1.07 ± 0.23  1.33 ± 0.20 1.25 ± 0.22  1.33 ± 0.20 1.33 ± 0.20 
Stride length  
(m) 
1.18 ± 0.20 1.13 ± 0.20  1.20 ± 0.23 1.19 ± 0.24  1.35 ± 0.17 1.31 ± 0.17  1.34 ± 0.18 1.36 ± 0.16 
Stride frequency  
(Hz) 
0.90 ± 0.07 0.93 ± 0.15  0.90 ± 0.07 0.93 ± 0.09  0.98 ± 0.07 0.95 ± 0.09  1.00 ± 0.09 0.98 ± 0.08 
CV of stride length 
(%) 
4.27 ± 2.52 4.63 ± 2.44  1.73 ± 0.93 1.54 ± 0.76  2.65 ± 1.00 3.35 ± 1.41  1.56 ± 0.84 1.56 ± 0.83 
CV of stride 
frequency (%) 
2.60 ± 0.80 2.96 ± 0.94  1.90 ± 1.12 1.88 ± 1.07  1.84 ± 0.53 2.37 ± 0.91  2.91 ± 1.97 2.80 ± 2.01 
            
 
Values are mean ± SD. 
PD indicates Parkinson disease; ST, single task; DT, dual task; CV, coefficient of variation. 
Table 3. ANOVA results of gait variables 
 Surface Task Group 
Surface x 
Task 
Surface x 
Group 
Task x 
Group 
Surface x 
Task x Group 
        
Gait speed (m/s)  
F = 46.76  
P < 0.001 
F = 12.03  
P = 0.001 
  NS NS 
Stride length (m) 
F = 8.00  
P = 0.008 
F = 21.32  
P < 0.001 
F = 6.73  
P = 0.001 
F = 29.77  
P < 0.001 
NS NS NS 
Stride frequency (Hz) NS NS 
F = 7.37  
P = 0.001 
NS NS NS NS 
CV of stride length 
(%) 
F = 73.35 NS 
F = 4.11  
P = 0.005 
F = 5.72  
P = 0.002 
F = 7.67  
P = 0.009 
NS NS 
CV of stride frequency 
(%) 
NS NS NS 
F = 4.65  
P = 0.004 
F = 11.71  
P = 0.002 
NS NS 
        
 
CV indicates coefficient of variation; NS, not significant 
Two-way ANOVA for gait speed showed a significant main effect for group and task factors (Table 
3), with higher overground speed in control participants compared with PD patients and also during ST 
compared with DT. No significant task × group interaction was found. 
Three-way ANOVA for stride frequency showed a significant main effect for group factor (Table 3). 
The control group walked with a higher stride frequency than the PD group. 
Three-way ANOVA for stride length revealed a significant surface × task interaction (Table 3). The 
post hoc analysis showed that for the ST condition, there were no significant differences in stride length 
between surfaces. However, the stride length was shorter for DT than for ST while walking overground 
(F = 44.30; P < 0.001), but there were no differences between DT and ST conditions during treadmill 
walking. On the treadmill, stride length for the DT condition was larger than for overground walking (F = 
24.26; P < 0.001). 
The analysis of the CV of stride frequency showed significant surface × group and surface × task 
interactions (Table 3) (Fig. 2). Therefore, there were no specific group effects of the task in this 
parameter. The post hoc analysis of the surface × group interaction showed that overground PD patients 
walked with a higher CV of stride frequency than control subjects (F = 8.67; P = 0.006). However, PD 
patients showed a lower CV than control subjects while walking on the treadmill (F = 4.10; P = 0.050) 
due to a decrease of the CV values in the PD group (F = 6.93; P = 0.01) and an increase of CV in control 
subjects when walking on the treadmill in comparison with walking overground (F = 4.87; P = 0.03). The 
post hoc analysis of the surface × task interaction indicated that the CV of stride frequency was higher 
during DT than during ST in the overground condition (F = 11.39; P = 0.002) but not in the treadmill 
condition.  
 
 
 
Figure 2 . Comparison of the coefficient of variation of stride frequency between single and dual 
task, in PD and control groups. PD indicates Parkinson disease; CV, coefficient of variation; ST, 
single task; DT, dual task. 
ANOVA showed significant surface × group and surface × task interactions (Table 3) for CV of stride 
length (Fig. 3). These results indicated that there were no specific group effects of the task on the CV of 
stride length. The post hoc analysis of the surface × group interaction showed that in overground 
condition, PD subjects walked with a higher CV of stride length compared with control participants (F = 
6.21; P = 0.017). However, these differences were not significant on the treadmill. This was due to a 
significant reduction of the CV, in both PD and control subjects, for treadmill versus overground walking 
(F = 64.23; P < 0.001 and F = 16.79; P < 0.001). The post hoc analysis of the surface × task interaction 
showed that the CV of stride length was higher for DT compared with ST while walking overground (F = 
4.39; P = 0.04), but there were no significant differences between the tasks on the treadmill. For treadmill 
walking, the CV was significantly lower than for overground walking for both the ST and DT condition 
(F = 48.20; P < 0.001 and F = 66.45; P < 0.001, respectively).  
 
 
 
Figure 3 . Comparison of the coefficient of variation of stride length between single and dual 
task, in PD and control groups. PD indicates Parkinson disease; CV, coefficient of variation; ST, 
single task; DT, dual task. 
The Wilcoxon test in the control group did not show differences on cognitive performance between 
baseline, overground, and treadmill conditions. However, the PD group showed significant differences 
between baseline and treadmill (Z = 2.550; P = 0.011). PD patients had a greater percentage of mistakes 
during treadmill walking compared with baseline. No differences were found between baseline and 
overground (Z = 1.221; P = 0.222) or between overground and treadmill walking (Z = 0.101; P = 0.92) in 
the PD group. Mann–Whitney tests did not show cognitive differences between groups in the three task 
conditions. However, there was a tendency for a higher percentage of mistakes in PD participants in 
comparison with controls during overground (Z = 1.929; P = 0.054) and treadmill (Z = 1.875; P = 0.061) 
walking (Fig. 4). 
 
 
 
Figure 4 . Comparison of cognitive performance between control and PD subjects for baseline, 
overground, and treadmill conditions. 
Discussion 
The main goal of this study was to explore whether attentional resources may explain the gait 
improvements observed during treadmill walking in PD. The results show that during treadmill walking 
with and without the cognitive tasks, individuals with PD reduced their gait variability. These gait 
improvements did not deteriorate during the performance of a concurrent cognitive task. Moreover, 
cognitive performance did not show statistical differences between treadmill and overground walking. 
Therefore, these findings suggest that improvements of gait in PD patients during treadmill walking are 
independent of attentional demands to the task of walking. 
Differences in Gait Parameters Between Surfaces 
The results showed that the PD group demonstrated a shorter stride length, lower velocity, and higher 
gait variability compared with the control group while walking overground. However, the PD group 
reduced the CV of stride frequency and the CV of stride length when walking on the treadmill. The 
reduction of the stride frequency variability during treadmill walking has been previously reported in 
PD.
18
 However, to our knowledge, the current study is the first to report a reduction in the variability of 
stride length. This is of relevance because a high stride-to-stride variability was associated with an 
increased risk of falls in PD.
29,30
 Therefore, the present investigation extends the benefits of this device, 
suggesting that walking on the treadmill could normalize the temporal variability as well as spatial gait 
variability in PD. 
Differences in Gait Between Tasks 
The present data clearly demonstrate that during the performance of a secondary cognitive task, all the 
participants displayed a decrease in the length of the step and speed together with an increase in the 
spatial and temporal variability of overground gait. This is in line with previous studies that showed a 
deterioration of gait disturbances in people with PD when they walk and perform a secondary task at the 
same time.
3,20,22,27
 Other studies have also shown alterations of the gait pattern in healthy older adults 
while simultaneously performing a cognitive task, suggesting an age-related reduction in dual task 
capacity.
21,31
 Moreover, there was a nonsignificant tendency, in PD participants, to perform the cognitive 
task during walking worse than control subjects. This tendency is in agreement with previous studies 
showing that PD individuals require more attention to regulate the gait pattern to compensate their 
damaged automaticity.
21
 Therefore, this report reinforces the hypothesis that walking during the 
performance of a cognitive task requires greater levels of cognitive function in PD patients.
32
 
  
The cognitive task did not affect any gait parameters during treadmill walking in PD and control 
subjects. Overall, the gait variability reduction in PD participants, as a result of walking on the treadmill, 
did not deteriorate during the performance of the cognitive task. Therefore, the present study suggests that 
the adaptative changes of the gait pattern while walking on a treadmill are not related to increased 
attentional demands in comparison with walking overground. 
In the present work, PD patients showed deterioration in their cognitive performance during treadmill 
walking in comparison with performing a cognitive task in a static position (baseline cognitive 
measurement). Previous studies showed that when the environment becomes more demanding, focusing 
on the cognitive task becomes too risky and the attention is allocated toward postural stability to reduce 
the likelihood of falling and secure safety.
33
 We cannot rule out the possibility that the handrail support 
during treadmill walking could “free up” attentional resources related to postural control and stability. 
Nevertheless, this study suggests that, despite the handrail support, DT dual task on a treadmill could be 
more demanding for PD participants compared with performing a cognitive task in a rest position without 
a simultaneous motor task. 
Mechanisms of Treadmill Walking in PD 
This article provides additional data to elucidate the role of attentional resource allocation in the 
treadmill-associated gait improvements observed in patients with PD. 
One of the hypotheses to explain the gait improvements in PD subjects is that they are able to allocate 
more attention to walking on a treadmill than walking overground.
19
 Previous studies showed that people 
with PD can normalize gait pattern when focusing attention on gait.
21
 However, during the performance 
of daily activities, distracters impede attention allocation with the consequent gait deterioration.6 During 
treadmill walking, the environment is more stable and the absence of distracters could help PD subjects to 
maintain their focus on the gait. The present study does not support this hypothesis. The results reported 
that CV of stride frequency was reduced during treadmill walking in both ST and DT conditions (Figs. 2–
3). Moreover, an absence of differences in cognitive performance between treadmill and overground 
walking in PD was observed. Therefore, these findings suggest that attentional demands do not contribute 
to the gait improvements in PD. 
Alternative explanations for the gait improvements are the belt displacement and the constant speed 
provided by the treadmill.
18–20
 The belt displacement enhances the hip extension movements during 
treadmill walking. These proprioceptive inputs (repeated contraction and relaxation of muscles groups) 
may act as an external rhythmical cue bypassing the defective pallidocortical projections, resulting in a 
normalized gait pattern.
20
 In addition, the propioceptive inputs during treadmill walking could stimulate 
the Central Pattern Generator (CPG). CPG refers to neural spinal circuits that can produce rhythmic 
movements. However, the role of CPG in human control remains unknown.
34
 The constant speed 
provided by the treadmill could also contribute to minimizing the stride-to-stride variation in gait 
timing,
18
 in contrast to overground walking where there are ongoing fluctuations in gait speed. The study 
results showed a reduction in both stride length and frequency variability on the treadmill in PD patients, 
in comparison with overground. Thus, PD patients could benefit from a constant speed, which improves 
gait timing. A recent study has suggested that the improvement in the step length may be due to the belt 
movement but that changes in variability may be influenced further by the imposed treadmill speed.
20
 
Although all subjects walked on the treadmill with the handrail support, it is unlikely that this could 
account for the gait improvement in subjects with PD. A previous study from our group clearly showed 
that when PD subjects walked with a treadmill simulator without the belt but with hand support, stable 
environment, and imposed speed, their step length did not improve in comparison with normal 
overground walking.
20
 Thus, hand support may not be responsible for the gait improvements during 
treadmill walking that were observed in the present study. 
In summary, this is the first study that explores the role of attention in the gait improvements observed 
in PD subjects during treadmill walking. The present results show that PD subjects walking on a 
treadmill, while simultaneously performing a cognitive task, are able to maintain the reduction of their 
gait variability. Moreover, their cognitive execution was similar during treadmill and overground 
walking. These findings suggest that attentional resources are not involved in the gait treadmill 
improvements in PD subjects and point to belt displacement and constant speed as alternative 
explanations. 
  
Clinical Implications 
The present study provides additional information that may be useful when considering the treadmill as a 
therapeutic tool to improve the gait in subjects with PD. The reduction of gait variability walking on a 
treadmill did not deteriorate during the performance of a concurrent cognitive task. Therefore, therapists 
may include performance of cognitive tasks during the treadmill walking to simulate real-life conditions 
(ie, walking while keeping a conversation). In addition, we recommend further studies that investigate the 
role of belt displacement and constant speed in gait improvements using treadmill walking in PD and to 
determine how these improvements translate to real-life conditions. 
Study Limitations 
There are several limitations in this study that must be addressed. First, there were no improvements 
in the stride length when walking on the treadmill because the severity of the disease of the PD 
participants in our study was moderate. It has been reported that improvements in stride length walking 
on a treadmill is specific to advanced PD patients.
17
 Thus, the role of attention over the improvement in 
the stride length remains unknown. Second, the participants did not show cognitive deficits as assessed by 
the Mini-Mental State Examination (MMSE). However, this does not exclude possible mild cognitive and 
attentional deficits in the PD participants.
35
 A comprehensive neuropsychological examination should be 
used to explore in more detail the executive and cognitive deficits in PD. Third, PD patients were tested 
only in ON state. ON medication may have impacted cognitive and gait performance because it is known 
that dual-task walking deficits are improved by anti-Parkinson medications.
36
 Thus, our conclusions may 
not be applicable to patients in OFF state. Finally, we have only focused on one dual-task model 
(attention capacity-sharing model). Other types of dual tasking models would help to describe a different 
cognitive processing that our study is not able to discern. In addition, the use of a more difficult cognitive 
task could outweigh the “freed-up” attentional demand by the handrail support and help to further 
delineate differences between conditions and groups. 
Conclusions 
The present results suggest that attentional resources do not influence the gait improvements observed 
in individuals with PD during treadmill walking. This study reinforces the hypothesis that belt 
displacement and constant speed are the main underlying mechanisms of treadmill walking improvements 
in PD. 
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